{"id":"https://openalex.org/W1551637372","doi":"https://doi.org/10.1111/j.1442-2042.2011.02761.x","title":"Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib","display_name":"Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib","publication_year":2011,"publication_date":"2011-04-11","ids":{"openalex":"https://openalex.org/W1551637372","doi":"https://doi.org/10.1111/j.1442-2042.2011.02761.x","mag":"1551637372","pmid":"https://pubmed.ncbi.nlm.nih.gov/21481012"},"language":"en","primary_location":{"id":"doi:10.1111/j.1442-2042.2011.02761.x","doi":"https://doi.org/10.1111/j.1442-2042.2011.02761.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1442-2042.2011.02761.x","pdf_url":null,"source":{"id":"https://openalex.org/S134892809","display_name":"International Journal of Urology","issn_l":"0919-8172","issn":["0919-8172","1442-2042"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Urology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5115594460","display_name":"Hai\u2010Liang Zhang","orcid":"https://orcid.org/0009-0007-1732-5548","observed_orcids":["https://orcid.org/0009-0007-1732-5548"]},"institutions":[{"id":"https://openalex.org/I24943067","display_name":"Fudan University","ror":"https://ror.org/013q1eq08","country_code":"CN","type":"education","lineage":["https://openalex.org/I24943067"]},{"id":"https://openalex.org/I4210093194","display_name":"Fudan University Shanghai Cancer Center","ror":"https://ror.org/00my25942","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093194"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hai\u2010Liang Zhang","raw_affiliation_strings":["Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China","Departments of Urology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China","institution_ids":["https://openalex.org/I24943067","https://openalex.org/I4210093194"]},{"raw_affiliation_string":"Departments of Urology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101567070","display_name":"Yao Zhu","orcid":"https://orcid.org/0009-0000-6731-4475","observed_orcids":["https://orcid.org/0009-0000-6731-4475"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yao Zhu","raw_affiliation_strings":["Departments of Urology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Urology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Chao\u2010Fu Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093194","display_name":"Fudan University Shanghai Cancer Center","ror":"https://ror.org/00my25942","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093194"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chao\u2010Fu Wang","raw_affiliation_strings":["Pathology, Fudan University Shanghai Cancer Center, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology, Fudan University Shanghai Cancer Center, Shanghai, China","institution_ids":["https://openalex.org/I4210093194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023666246","display_name":"Xudong Yao","orcid":"https://orcid.org/0000-0001-6207-8514","observed_orcids":["https://orcid.org/0000-0001-6207-8514"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xu\u2010Dong Yao","raw_affiliation_strings":["Departments of Urology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Urology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Shi\u2010Lin Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shi\u2010Lin Zhang","raw_affiliation_strings":["Departments of Urology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Urology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062711588","display_name":"Bo Dai","orcid":"https://orcid.org/0000-0002-0029-792X","observed_orcids":["https://orcid.org/0000-0002-0029-792X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bo Dai","raw_affiliation_strings":["Departments of Urology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Urology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yi\u2010Jun Shen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yi\u2010Jun Shen","raw_affiliation_strings":["Departments of Urology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Urology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100721292","display_name":"Yiping Zhu","orcid":"https://orcid.org/0000-0001-8015-420X","observed_orcids":["https://orcid.org/0000-0001-8015-420X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yi\u2010Ping Zhu","raw_affiliation_strings":["Departments of Urology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Urology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082443535","display_name":"Guohai Shi","orcid":"https://orcid.org/0000-0002-7260-1396","observed_orcids":["https://orcid.org/0000-0002-7260-1396"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guo\u2010Hai Shi","raw_affiliation_strings":["Departments of Urology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Urology and","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053347862","display_name":"Dingwei Ye","orcid":"https://orcid.org/0000-0002-6761-5195","observed_orcids":["https://orcid.org/0000-0002-6761-5195","https://orcid.org/0000-0003-4974-3780"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ding\u2010Wei Ye","raw_affiliation_strings":["Departments of Urology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Urology and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5053347862"],"corresponding_institution_ids":[],"apc_list":{"value":3570,"currency":"USD","value_usd":3570},"apc_paid":null,"fwci":2.1754,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.86990766,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"18","issue":"6","first_page":"422","last_page":"430"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erythrocyte-sedimentation-rate","display_name":"erythrocyte sedimentation rate","score":0.9810000061988831},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9860000014305115},{"id":"https://openalex.org/keywords/clear-cell-renal-cell-carcinoma","display_name":"clear cell renal cell carcinoma","score":0.8700000047683716},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":1.0},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7749999761581421},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9480000138282776},{"id":"https://openalex.org/keywords/treatment-response-monitoring","display_name":"treatment response monitoring","score":0.9229999780654907},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/chinese-patients","display_name":"Chinese patients","score":0.6710000038146973}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9353681802749634},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.8700776100158691},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.7358189225196838},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6939547657966614},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.6249529123306274},{"id":"https://openalex.org/C2778143017","wikidata":"https://www.wikidata.org/wiki/Q111208","display_name":"Erythrocyte sedimentation rate","level":2,"score":0.5683028101921082},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5381696224212646},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.46716558933258057},{"id":"https://openalex.org/C2777318727","wikidata":"https://www.wikidata.org/wiki/Q409464","display_name":"Lactate dehydrogenase","level":3,"score":0.4557305574417114},{"id":"https://openalex.org/C2780227381","wikidata":"https://www.wikidata.org/wiki/Q1357376","display_name":"Nephrectomy","level":3,"score":0.44338458776474},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.435324490070343},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.42960885167121887},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.41983193159103394},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.41396385431289673},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39727258682250977},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.31833845376968384},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.19699707627296448},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.19549161195755005},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.15607309341430664},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.10828256607055664},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077157","descriptor_name":"Sorafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001557","descriptor_name":"Benzenesulfonates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001799","descriptor_name":"Blood Sedimentation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1442-2042.2011.02761.x","doi":"https://doi.org/10.1111/j.1442-2042.2011.02761.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1442-2042.2011.02761.x","pdf_url":null,"source":{"id":"https://openalex.org/S134892809","display_name":"International Journal of Urology","issn_l":"0919-8172","issn":["0919-8172","1442-2042"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Urology","raw_type":"journal-article"},{"id":"pmid:21481012","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21481012","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of urology : official journal of the Japanese Urological Association","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W60629781","https://openalex.org/W1771354333","https://openalex.org/W1883934225","https://openalex.org/W1963741397","https://openalex.org/W1965037168","https://openalex.org/W1971358860","https://openalex.org/W1971894005","https://openalex.org/W1975946590","https://openalex.org/W1992532818","https://openalex.org/W1998026546","https://openalex.org/W1999966467","https://openalex.org/W2023161326","https://openalex.org/W2024251485","https://openalex.org/W2034269086","https://openalex.org/W2046252805","https://openalex.org/W2082331198","https://openalex.org/W2084778105","https://openalex.org/W2100669312","https://openalex.org/W2115201803","https://openalex.org/W2116554142","https://openalex.org/W2118677643","https://openalex.org/W2135400147","https://openalex.org/W2135953817","https://openalex.org/W2137822543","https://openalex.org/W2138822094","https://openalex.org/W2143813821","https://openalex.org/W2149456801","https://openalex.org/W2153867442","https://openalex.org/W2156503630","https://openalex.org/W2414318888","https://openalex.org/W2428660931","https://openalex.org/W2434460620"],"related_works":["https://openalex.org/W1535129627","https://openalex.org/W2428660931","https://openalex.org/W1652253116","https://openalex.org/W60629781","https://openalex.org/W2177259129","https://openalex.org/W2964700594","https://openalex.org/W2120927187","https://openalex.org/W2560703380","https://openalex.org/W1975946590","https://openalex.org/W2598512459"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Previous":[1],"prognostic":[2,26],"factor":[3],"models":[4],"for":[5,30,194,235],"metastatic":[6,82,186],"renal":[7],"cell":[8,45],"carcinoma":[9],"(mRCC)":[10],"have":[11],"not":[12],"included":[13,72],"erythrocyte":[14],"sedimentation":[15],"rate":[16],"(ESR).":[17],"We":[18],"designed":[19],"the":[20,25,141,157,164,172,206,228],"present":[21],"study":[22],"to":[23,40,116,147,181,226,232],"evaluate":[24],"value":[27],"of":[28,60,78,81,185,208,216],"ESR":[29,48,91,94,111,125,148,159,166,174,189,221],"mRCC":[31,236],"patients":[32,42,122,237],"treated":[33,238],"with":[34,43,202,239],"sorafenib.":[35,61],"METHODS:":[36],"Sorafenib":[37],"was":[38,49,64,133,153],"given":[39],"83":[41],"clear":[44],"mRCC.":[46],"Serum":[47],"tested":[50],"before":[51],"treatment":[52,229],"and":[53,93,98,119,168,188,231],"every":[54,67],"4":[55],"weeks":[56],"after":[57],"first":[58],"administration":[59],"Oncological":[62],"evaluation":[63],"carried":[65,107],"out":[66],"8":[68],"weeks.":[69],"Analyzed":[70],"factors":[71],"age,":[73],"sex,":[74],"performance":[75],"status,":[76,150,177],"method":[77],"nephrectomy,":[79],"number":[80,184],"organs,":[83],"anemia,":[84],"lactate":[85],"dehydrogenase,":[86],"corrected":[87],"calcium,":[88],"albumin,":[89],"baseline":[90],"level":[92,126],"kinetics":[95,149,190,222],"status.":[96],"Kaplan-Meier":[97],"Cox":[99,198],"regression":[100,199,214],"analyses":[101],"on":[102],"progression-free":[103],"survival":[104],"(PFS)":[105],"were":[106,191],"out.":[108],"RESULTS:":[109],"Baseline":[110],"levels":[112],"ranged":[113],"from":[114,179],"3":[115],"154":[117],"mm/h,":[118],"43":[120],"(41.0%)":[121],"had":[123],"an":[124,203],"higher":[127],"than":[128],"40":[129],"mm/h.":[130],"Median":[131],"PFS":[132,152,195,218,234],"10.0":[134],"months":[135,155,162,170],"(95%":[136],"CI":[137],"7.6-12.4":[138],"months).":[139],"Dividing":[140],"cohort":[142],"into":[143],"three":[144],"groups":[145],"according":[146],"median":[151],"27":[154],"in":[156,163,171,196,210],"decreased":[158],"group,":[160],"12":[161],"stable":[165],"group":[167],"6":[169],"increased":[173],"group.":[175],"Performance":[176],"time":[178],"diagnoses":[180],"sorafenib":[182,240],"treatment,":[183],"organs":[187],"independent":[192],"predictors":[193],"multivariable":[197],"model":[200,215],"analysis,":[201],"area":[204],"under":[205],"curve":[207],"0.865":[209],"a":[211],"binary":[212],"logistic":[213],"12-month":[217],"probability.":[219],"CONCLUSIONS:":[220],"can":[223],"be":[224],"useful":[225],"monitor":[227],"response":[230],"predict":[233],"as":[241],"second-line":[242],"therapy.":[243]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}